Found 550 matching trials
Nutritional Supplementation of Flavonoids Quercetin and Curcumin for Early Mild Symptoms of COVID-19
NAThe purpose of this study is to investigate the therapeutic benefits of fla...
Location
King Edward Medical University Teaching Hospital
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
PHASE2The purpose of this research study is to explore ways to improve motor, cog...
Location
Washington University School of Medicine
Supplement Combination on Stress and Sleep
NAThe purpose of this clinical trial is to assess the effects of a supplement...
Location
University of South Carolina Sport Science Lab
Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
PHASE4The randomized clinical study aimed to assess the efficacy and safety of st...
Location
Clinical Hospital no.1 of the President's Administration of Russian Federation
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
PHASE2Toxicities related to pediatric cancer treatment can lead to significant il...
Location
University of Virginia
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
PHASE2This phase II trial tests how well giving dasatinib and quercetin with cycl...
Location
Mayo Clinic in Rochester
Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus Silibinin
NAThe occurrence of brain metastases (BMs) is increasing given the availabili...
Status
Active Not Recruiting
Location
IRCCS Humanitas Research Hospital
Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major
PHASE1A wide spectrum of immune abnormalities has been described by numerous stud...
Location
Department of Immunology, School of Medicine, Shiraz University of Medical Sciences
Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy
NARATIONALE: Eating a diet rich in soy foods may slow the progression of some...
Location
CCOP - Western Regional, Arizona
(-)- Epicatechin Becker Muscular Dystrophy
PHASE2This is a 48-week open-label extension of our initial proof-of-concept stud...
Location
UC Davis Medical Center